Latest Breaking News On - இணை தலைமை நிர்வாகி அதிகாரிகள் - Page 6 : comparemela.com

Century Casinos Re-Opens Casinos in Poland

Century Casinos Re-Opens Casinos in Poland
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United statesCape girardeauCripple creekCentral cityWest virginiaNew cumberlandPeter hoetzingerErwin haitzmannCasinos poland ltdCentury casino hotels in cripple creekCentury casinos incSecurities exchangeCo chief executive officersCentury casinosCentury casinoMountaineer casino

Acies Acquisition Corp Announces Special Meeting Date to Approve Proposed Business Combination with PLAYSTUDIOS, Inc – Consumer Electronics Net

Acies Acquisition Corp Announces Special Meeting Date to Approve Proposed Business Combination with PLAYSTUDIOS, Inc – Consumer Electronics Net
consumerelectronicsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from consumerelectronicsnet.com Daily Mail and Mail on Sunday newspapers.

Jacques cornetEdward kingJim murrenExchange commissionPlaystudios incCompany doAcies acquisition corpMorrow sodaliAcies or companySpecial meetingStockholders scheduledAcies acquisitionBusiness combinationRegistration statementProxy statementInformation about

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021 ACCESSWIRE 14 May 2021, 04:05 GMT+10 HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended March 31, 2021. Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%. The Company had operating income of $1.7 million and $1.0 million in the quarters ended March 31, 2021 and 2020, respectively. Revenues for the nine-month period ended March 31, 2021 were $46.5 million compared to $39.2 million for the nine-month period ended March 31, 2020, an increase of $7.3 million or 18.6%. The Company had operating income for the nine-month period ended March 31, 2021 of $4.5 million compared to operating income of $2.6 million for the nine-month period ended March 31, 2020.

Dina masiChristina kayRiva sheppardBiopharma incOfficers of the companyIntegrated biopharmaContract manufacturing segmentCo chief executive officersPrivate securities litigation reform actRisk factorAnnual reportQuarterly reportsதினா மாசிகிறிஸ்டினா காய்ரீவ ஷெப்பர்ட்அதிகாரிகள் ஆஃப் தி நிறுவனம்

SMIC Reports 2021 First Quarter Results

SMIC Reports 2021 First Quarter Results All currency figures stated in this report are in US Dollars unless stated otherwise. The consolidated financial statements are prepared in accordance with International Financial Reporting Standards ( IFRS ). News provided by Share this article Share this article SHANGHAI, May 13, 2021 /PRNewswire/ Semiconductor Manufacturing International Corporation (SSE STAR MARKET: 688981; SEHK: 00981) ( SMIC , the Company or we ), one of the leading semiconductor foundries in the world, today announced its consolidated results of operations for the three months ended March 31, 2021. 20 Quarter Highlights Revenue was $1,103.6 million in 1Q21, an increase of 12.5% QoQ from $981.1 million in 4Q20, and 22.0% YoY from $904.9 million in 1Q20.

Hong kongGao yonggangHaijun zhaoSemiconductor manufacturing international corporationInternational financial reporting standardsPrnewswire semiconductor manufacturing international corporationStock exchange of hong kong limitedShanghai stock exchangeManufacturing international corporationChief financial officerLiang mong songMainland chinaTaiwan chinaCo chief executive officersChief financialStock exchange

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021 ACCESSWIRE 14 May 2021, 04:05 GMT+10 HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended March 31, 2021. Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%. The Company had operating income of $1.7 million and $1.0 million in the quarters ended March 31, 2021 and 2020, respectively. Revenues for the nine-month period ended March 31, 2021 were $46.5 million compared to $39.2 million for the nine-month period ended March 31, 2020, an increase of $7.3 million or 18.6%. The Company had operating income for the nine-month period ended March 31, 2021 of $4.5 million compared to operating income of $2.6 million for the nine-month period ended March 31, 2020.

Dina masiChristina kayRiva sheppardBiopharma incOfficers of the companyIntegrated biopharmaContract manufacturing segmentCo chief executive officersPrivate securities litigation reform actRisk factorAnnual reportQuarterly reportsUnited states wire groupதினா மாசிகிறிஸ்டினா காய்ரீவ ஷெப்பர்ட்